Table 4.
Distribution of study subjects by PTEN and Her2/new immunohistochemical expression.
| Lesion type | PTEN | Total | Her2/neu | Total | ||
|---|---|---|---|---|---|---|
| −Ve | +ve | −Ve | +ve | |||
| Carcinoma SBR | 0 | 0 | 0 | 1 | 0 | 1 |
| Infiltrating DC | 3 | 30 | 33 | 39 | 8 | 47 |
| Invasive DC | 5 | 85 | 90 | 109 | 24 | 133 |
| RIDC | 0 | 2 | 2 | 1 | 1 | 2 |
| Intracystic carcinoma | 0 | 0 | 0 | 0 | 1 | 1 |
| Ductal carcinoma in situ | 1 | 10 | 11 | 3 | 0 | 3 |
| MDF adenocarcinoma | 0 | 11 | 11 | 2 | 0 | 2 |
| PDFC | 1 | 5 | 6 | 1 | 1 | 2 |
| MANS | 1 | 0 | 1 | 1 | 0 | 1 |
| Metastatic ductal ca | 0 | 5 | 5 | 2 | 0 | 2 |
| Invasive lobular ca | 0 | 4 | 4 | 6 | 2 | 8 |
| Others | 5 | 8 | 13 | 0 | 0 | 0 |
| Total | 16 | 160 | 176 | 165 | 37 | 202 |